GPT Healthcare Limited announced its unaudited financial results for the first quarter ended June 30, 2026 (Q1 FY27), in compliance with SEBI Listing Regulations (Regulation 30 read with Part A of Schedule III).

Financial Performance

Total Income: ₹128.2 crore, representing 18.0% year-over-year (YoY) growth from Q1 FY26 (₹108.7 crore) and 0.2% quarter-over-quarter (QoQ) growth from Q4 FY26 (₹128.0 crore).

EBITDA: ₹26.2 crore, showing 38.5% YoY growth from Q1 FY26 (₹18.9 crore) and 4.9% QoQ growth from Q4 FY26 (₹25.0 crore).

EBITDA Margin: 20.4%, compared to 17.4% in Q1 FY26 and 19.5% in Q4 FY26.

Profit After Tax (PAT): ₹12.7 crore, demonstrating 65.7% YoY growth from Q1 FY26 (₹7.7 crore) but a 12.6% QoQ decline from Q4 FY26 (₹14.6 crore).

PAT Margin: 9.9%, compared to 7.1% in Q1 FY26 and 11.4% in Q4 FY26.

Full Year FY26 Reference: Total Income of ₹478.5 crore, EBITDA of ₹90.1 crore (18.8% margin), and PAT of ₹42.2 crore (8.8% margin).

Operational Highlights

  • Average Revenue Per Occupied Bed (ARPOB): Maintained at ₹42,350.
  • Occupancy Rates: 58.07% (excluding the newly commenced Raipur facility); 45.5% (including Raipur facility).
  • ILS Dum Dum: Completed over 700 renal transplants.
  • ILS Howrah: Launched Robotic Knee Surgery programme using MAKO system.
  • ILS Agartala: Delivered over 700 radiation therapy procedures.
  • ILS Salt Lake: Surpassed 800 robotic surgeries.
  • ILS Raipur: Received liver transplant license; expected to break even by Q3 FY27.
  • Jamshedpur Hospital: On track for completion by Q4 FY27.
  • Clinical Research: Participation in the BEMAKI acute kidney injury trial strengthened clinical research footprint.

Management Commentary

Dr. Om Tantia, Chairman, commented on the company's strategy:

  • Improving occupancy across mature hospitals
  • Ramping up newer facilities
  • Strengthening presence in underserved, high-density markets
  • Expanding high-value specialties and introducing services aligned with patient demand
  • Increasing adoption of robotic-assisted and minimally invasive procedures
  • Strengthening doctor and insurance networks
  • Finalizing seventh hospital to increase total network capacity to more than 1,000 beds
  • Maintaining net-debt-free position
  • Focus on standardized clinical governance, care quality, patient outcomes, and operational efficiency

Company Overview

GPT Healthcare Limited operates the ILS Hospitals brand, a tertiary-care hospital platform in Eastern India with five multi-specialty hospitals:

  • ILS Salt Lake: 85 beds
  • ILS Agartala: 205 beds
  • ILS Dumdum: 155 beds
  • ILS Howrah: 116 beds
  • ILS Raipur: 158 beds

Total network capacity: 719 beds across Eastern Indian markets, strategically located within high-density residential catchments.